Efficacy of as-needed intravitreal injection compared to 3-monthly loading of anti-vascular endothelial growth factor agents for branch retinal vein occlusion
Abstract We investigated the efficacy of intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents in branch retinal vein occlusion (BRVO). Databases, including PubMed, EMBASE, and the Cochrane Library, were searched on November 11, 2022. Studies comparing the pro-re-nata (PRN)...
Main Authors: | Yoo-Ri Chung, Tae Kyoung Woo, Ha Ryung Park, Kihwang Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-39303-2 |
Similar Items
-
Intravitreal injection of Conbercept for macular edema due to branch retinal vein occlusion
by: Qi Cai, et al.
Published: (2018-05-01) -
Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
by: Jing Wang, et al.
Published: (2020-07-01) -
Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections
by: X. Chen, et al.
Published: (2020-06-01) -
Intravitreous injection with ranibizumab combined laser photocoagulation for the treatment of branch retinal vein occlusion
by: Xiao-Bo Wang, et al.
Published: (2013-12-01) -
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
by: Thapa R, et al.
Published: (2012-07-01)